Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hair Cells, Auditory | 3 | 2017 | 64 | 0.730 |
Why?
|
| Anion Transport Proteins | 1 | 2016 | 34 | 0.540 |
Why?
|
| Cell Membrane | 1 | 2016 | 878 | 0.420 |
Why?
|
| Antioxidants | 1 | 2015 | 521 | 0.390 |
Why?
|
| Trehalose | 2 | 2018 | 25 | 0.300 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 4130 | 0.240 |
Why?
|
| Cerebral Palsy | 1 | 2023 | 86 | 0.200 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 16 | 0.180 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 93 | 0.180 |
Why?
|
| Disabled Persons | 1 | 2020 | 109 | 0.160 |
Why?
|
| Acetylglucosaminidase | 1 | 2018 | 19 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 241 | 0.150 |
Why?
|
| Hearing Loss | 2 | 2017 | 172 | 0.150 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 212 | 0.150 |
Why?
|
| Retinal Degeneration | 1 | 2018 | 97 | 0.150 |
Why?
|
| Mental Health Services | 1 | 2020 | 258 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2020 | 287 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 326 | 0.140 |
Why?
|
| Electric Capacitance | 1 | 2016 | 13 | 0.140 |
Why?
|
| Gerbillinae | 1 | 2016 | 57 | 0.140 |
Why?
|
| Ion Transport | 1 | 2016 | 65 | 0.140 |
Why?
|
| Length of Stay | 1 | 2023 | 2007 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 76 | 0.130 |
Why?
|
| Hippocampus | 2 | 2020 | 919 | 0.130 |
Why?
|
| Hair Cells, Auditory, Outer | 1 | 2016 | 69 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 628 | 0.130 |
Why?
|
| Cochlea | 1 | 2016 | 118 | 0.130 |
Why?
|
| Electrophysiology | 1 | 2016 | 350 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 7100 | 0.130 |
Why?
|
| Doxycycline | 1 | 2016 | 179 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 398 | 0.120 |
Why?
|
| Betacoronavirus | 1 | 2020 | 514 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 220 | 0.120 |
Why?
|
| Membrane Potentials | 1 | 2016 | 436 | 0.120 |
Why?
|
| Movement Disorders | 1 | 2017 | 234 | 0.120 |
Why?
|
| Autophagy | 2 | 2018 | 911 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 275 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2016 | 307 | 0.110 |
Why?
|
| Organ of Corti | 1 | 2013 | 27 | 0.110 |
Why?
|
| Alleles | 2 | 2017 | 2600 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 625 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 700 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2016 | 1461 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 517 | 0.100 |
Why?
|
| Cell Survival | 2 | 2015 | 3063 | 0.100 |
Why?
|
| Neurons | 3 | 2017 | 2439 | 0.090 |
Why?
|
| Animals | 10 | 2020 | 61956 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2013 | 310 | 0.090 |
Why?
|
| Chromosome Disorders | 1 | 2013 | 423 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1730 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2069 | 0.080 |
Why?
|
| Aging | 1 | 2017 | 1534 | 0.080 |
Why?
|
| Brain | 3 | 2018 | 4208 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 2518 | 0.080 |
Why?
|
| Mice | 7 | 2020 | 35600 | 0.080 |
Why?
|
| Chromosome Deletion | 1 | 2013 | 1049 | 0.080 |
Why?
|
| Repressor Proteins | 2 | 2013 | 1718 | 0.080 |
Why?
|
| Gene Expression | 1 | 2016 | 3640 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 1503 | 0.070 |
Why?
|
| Disease Progression | 1 | 2018 | 6867 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 1023 | 0.070 |
Why?
|
| Insect Hormones | 1 | 2005 | 16 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1581 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2005 | 167 | 0.060 |
Why?
|
| Astrocytes | 2 | 2018 | 400 | 0.060 |
Why?
|
| Time Factors | 2 | 2016 | 13006 | 0.060 |
Why?
|
| Muscle Relaxants, Central | 1 | 2023 | 39 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4223 | 0.060 |
Why?
|
| Baclofen | 1 | 2023 | 54 | 0.060 |
Why?
|
| Rhizotomy | 1 | 2023 | 23 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5776 | 0.060 |
Why?
|
| Rehabilitation Centers | 1 | 2023 | 72 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2023 | 145 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2018 | 1712 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2023 | 681 | 0.040 |
Why?
|
| Physical and Rehabilitation Medicine | 1 | 2020 | 48 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2020 | 5728 | 0.040 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2018 | 13 | 0.040 |
Why?
|
| Vacuoles | 1 | 2018 | 47 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 683 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2018 | 38 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 88 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2017 | 183 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 199 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2020 | 747 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 153 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 345 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 391 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 274 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 266 | 0.030 |
Why?
|
| Humans | 5 | 2023 | 270740 | 0.030 |
Why?
|
| Male | 7 | 2023 | 128315 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1111 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 680 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1076 | 0.030 |
Why?
|
| Labyrinth Supporting Cells | 1 | 2013 | 2 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 1685 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2013 | 20 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 300 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 1094 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 325 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 1192 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 354 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 242 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1610 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 1697 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 1654 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 746 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 875 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 2315 | 0.020 |
Why?
|
| Female | 5 | 2023 | 148940 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1368 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 4942 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1307 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2023 | 17061 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 9292 | 0.020 |
Why?
|
| Orthoptera | 1 | 2005 | 3 | 0.020 |
Why?
|
| Manduca | 1 | 2005 | 5 | 0.020 |
Why?
|
| Juvenile Hormones | 1 | 2005 | 7 | 0.020 |
Why?
|
| Insecta | 1 | 2005 | 87 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2005 | 65 | 0.020 |
Why?
|
| Proteins | 1 | 2013 | 2043 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2005 | 229 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 5457 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 7381 | 0.010 |
Why?
|
| Adolescent | 1 | 2023 | 32767 | 0.010 |
Why?
|
| United States | 1 | 2020 | 15861 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 33737 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 4116 | 0.010 |
Why?
|
| Child | 1 | 2023 | 30559 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 6509 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 39890 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2224 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 1504 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 12103 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 5056 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7655 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 4481 | 0.010 |
Why?
|